EMORY (US) — Infants whose mothers took DHA supplements during pregnancy had fewer colds and shorter illnesses at one, three, and six months of age, a new study finds.
“This is a large scale, robust study that underscores the importance of good nutrition during pregnancy,” says Usha Ramakrishnan, associate professor in the global health department at Emory University. “Our findings indicate that pregnant women taking 400 mg of DHA are more likely to deliver healthier infants.”
The randomized, placebo-controlled trial followed approximately 1,100 pregnant women and 900 infants in Mexico. The women were supplemented daily with 400 mg of Docosahexaenoic Acid (DHA) supplements in the algal form or placebo from 18 to 22 weeks gestation through childbirth. Findings are reported in the journal Pediatrics.
At one month of age, the infants in the DHA group experienced a reduced occurrence of cold symptoms by 25 percent, including a shorter duration of cough, phlegm, and wheezing.
At age three months, the infants in the DHA group spent 14 percent less time ill.
At six months of age, infants in the DHA group experienced shorter duration of fever, nasal secretion, difficulty breathing, and rash, though longer duration of vomiting.
Ramakrishnan and her colleagues have previously reported findings that show offspring of women pregnant with their first child who received 400 mg DHA during pregnancy delivered babies who were 100 grams heavier at birth and 3/4 cm longer at 18 months of age.
The study, funded by the National Institutes of Health and the March of Dimes Foundation, also found increased DHA levels in breast milk. All of the infants participating in the study were breastfed.
More news from Emory University: www.emory.edu/home/news